PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders Dec 15 • 3 min read PharmaTher Inc. announced that it has filed a provisional patent outlining the potential for novel combinations of psilocybin and U.S. Food and Drug Administration approved drugs to treat neurological disorders.
Seelos Therapeutics Raises $10 Million In Private Placement of Senior Secured Convertible Note Dec 14 • 4 min read Seelos Therapeutics, Inc. today announced the sale of a $12M senior secured convertible note and shares of Seelos common stock to investors.
MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m) Dec 11 • 4 min read Mind Medicine (MindMed) Inc. announced that it has closed its previously announced bought deal short form prospectus offering.
Better Plant Subsidiary NeonMind Announces Filing of Final Prospectus in Connection with an Initial Public Offering Dec 11 • 6 min read Better Plant Sciences Inc. announced that its majority-owned subsidiary NeonMind Biosciences Inc. obtained a receipt for a final prospectus for an initial public offering.
Tryp Therapeutics Files Final Prospectus and Announces Initial Public Offering Dec 10 • 4 min read Tryp Therapeutics Inc. announced that it has obtained a receipt for its final prospectus in connection with the initial public offering